再鼎醫藥-SB(09688.HK)聘請美國審計師KPMGLLP擔任公司獨立註冊會計師事務所
格隆匯4月21日丨再鼎醫藥-SB(09688.HK)公吿,於2022年4月18日,審核委員會亦批准分別解聘德勤華永會計師事務所(特殊普通合夥)及德勤•關黃陳方會計師行作為公司的獨立註冊會計師事務所及審計師。
於2022年4月18日,經公司董事會審核委員會進行審查程序後,審核委員會批准聘請美國審計師KPMGLLP就根據1934年證券交易法(經修訂)向美國證券交易委員會提交的公司及其子公司的年度合併財務報表以及公司的財務報吿內部控制擔任公司截至2022年12月31日止財政年度的獨立註冊會計師事務所。
KPMGLLP亦將受聘審計根據香港上市規則向香港聯合交易所有限公司提交的集團截至2022年12月31日止年度的合併財務報表,但須待公司收到香港聯交所及香港財務彙報局的必要批准後方可作實,預期該等批准為常規行政流程。公司聘請KPMGLLP與公司在美國的現有業務相契合。
截至本公吿日期,KPMGLLP正在完成其標準客户評估程序,包括就其獲委任為公司的審計師獲得香港聯交所的批准。完成該等標準程序後,KPMGLLP將簽署審計業務約定書並正式開始履職。
公司期待,此次聘請位於美國並接受美國公眾公司會計監察委員會檢查的審計事務所將幫助公司遵守《外國公司問責法案》的審計要求,並且在此前提下將有助於公司繼續於納斯達克掛牌上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.